Analysts Downgrade Lundin Mining En Masse After Guidance Update
On November 30th, Lundin Mining (TSX: LUN) provided their long-awaited three-year production guidance for 2021 to 2023, along with operational and cash cost expenditures for 2021. They also announced they would be increasing their quarterly dividend by 50%, renewing its Normal Course Issuer Bid, and reinstating their 2020 Candalaria guidance after coming to agreeance with […]
Last Mile Holdings Finds Itself On Its Last Leg
Last Mile Holdings (TSXV: MILE) appears to be on its last leg, with the company announcing last night that it was issued a notice of default by one of its secured lenders on November 27. An acceleration of the secured debt was also filed at the same time, with the company currently at risk of […]
US Government Has Been Underpaying and Miscounting Unemployment Recipients Ahead of December Covid-19 Benefits Expiry
As millions of Americans grapple with the fact that they are slated to have a less-than-joyous Christmas given the impeding expiration of unemployment benefits and eviction moratoriums come January 1, it appears that the US Department of Labour is partly to blame. According to a scathing report published by the General Accountability Office (GAO), the […]
Acreage Announces Funding For Illinois Cultivation Expansion
Acreage Holdings (CSE: ACRG.u) continues to see a high cost of capital, this morning announcing that it has entered into an arrangement to borrow money at an interest rate of 16% per annum over a term of 18 months. The financing is to be used to fund the expansion of its cultivation and processing facility […]
Numinus Wellness To Collaborate With MAPS On Proposed MDMA-Assisted Psychotherapy Trials
Numinus Wellness (TSXV: NUMI) this morning announced that it has entered into an arrangement with a subsidiary of the Multidisciplinary Association for Psychedelic Studies, also known as MAPS, to collaborate on a clinical trial that uses MDMA. The collaboration will see the duo collaborate for Health Canada approval to conduct an MDMA-assisted psychotherapy for PTSD […]
Exploits Discovery Identifies New Veins At Dog Bay With Visible Gold
Exploits Discovery Corp (CSE: NFLD) this morning announced that it has discovered several new sulphide bearing quartz veins along with multiple occurrences of visible gold at its Dog Bag Gold Project. The Dog Bay Gold project is located along both the Appleton Fault and Day Bay Line Fault within Newfoundland and Labrador. With regards to […]
Canntrust Cannabis Products To Return To Retailers This Month
In an announcement that will most certainly enrage countless legacy cannabis consumers and growers, Canntrust Holdings (OTC: CNTTQ) this morning announced that it is returning to the Canadian marketplace. Products under the firms brands Liiv and Synr.g are anticipated to hit retailer shelves this month, with further products to be made available early in the […]
C21 Investments Announces Planned Expansion Of Cultivation Operations
C21 Investments (CSE: CXXI) this morning announced expansion plans for its Nevada cultivation facility, with the company looking to add 40,000 square feet of cultivation space to its operation. The company currently anticipates that the expansion will be completed in the second half of 2021. The expansion will see what amounts to a reported 200% […]
Max Resource Corp Expands Herradura Zone To 29 Square Kilometres At Cesar
Further results were released by Max Resource Corp (TSXV: MXR) this morning from their Cesar copper-silver project located in northern Colombia. The latest results extend the Herradura copper-silver zone at the AM North portion of the property, with the highlight sample returning values of 7.2% copper and 55 g/t silver over 2.0 metres. The recent […]
Canaccord: CloudMD’s Third Quarter Results Were “In The Range Of Expectations”
On November 30th, CloudMD Software & Services (TSXV: DOC) reported its third-quarter financial results. CloudMD reported record revenue of $3.4 million, up 55% year over year and a gross margin of 42%. They had a net loss of $2.7 million or ($0.02) per share this quarter. CloudMD currently has four analysts covering the company with […]